EMEA-001602-PIP01-13-M01

Key facts

Active substance
grazoprevir
Therapeutic area
Infectious diseases
Decision number
P/0312/2015
PIP number
EMEA-001602-PIP01-13-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Belgium
Tel. +33 180464738
Email: pip.information@merck.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating